Solutions

Norovirus outbreak

Norovirus outbreak

Successfully tackling a Norovirus outbreak

Norovirus is associated with outbreaks of diarrhoea and vomiting which are usually not clinically significant. However, Norovirus outbreaks can cause significant financial and operational difficulties to a hospital.

The virus is extremely contagious and necessitates patient isolation and regular ward closure. Although clinical outcomes are not typically severe, Norovirus affects both patients and healthcare workers (HCWs).

Bed blocking caused by the virus restricts the ability of hospitals to generate revenue through additional admissions. Further, there are often substantial ‘catch-up’ costs relating to cancelled procedures.

Bioquell’s Norovirus Suppression Programme is designed to eliminate rapidly Norovirus from contaminated patient areas, reducing the risk of transmission and facilitating more efficient cohorting. Each plan is tailored to individual hospital requirements and allows hospitals to maximise the benefit of Bioquell’s technology and ensure full integration with any existing infection control bundles.

Our bespoke programme reduces the spread of Norovirus and helps generate significant cost-benefits.

Make an enquiry

> Larger preview

Our Solutions

Bioquell has developed the Norovirus Suppression Programme to overcome issues associated with the speed of Norovirus onset, the scale of environmental contamination and the operational issues it causes. Hospitals can combine their own preferred protocols and infection control bundles with Bioquell’s knowledge of contamination risk-management and control, alongside our best practice lessons learnt during ‘real world’ Norovirus deployments.

Bioquell’s Norovirus Suppression Programme is agreed in detail with the hospital in preparation for the onset of an outbreak and typically includes:

  • Working closely with the hospital’s infection control team to integrate Bioquell’s solutions with existing Norovirus remediation protocols or infection control bundles. Best practice on patient movement, PPE and access rules will be employed
  • The establishment of the process for initiating a high priority Bioquell bio-decontamination deployment
  • The trigger points and procedures that end a deployment
  • A recommendation to implement the Bioquell Committed Technology service to facilitate a quick and flexible response
  • Co-ordinated and agreed management information flow including updates on daily deployments and cost capture. Clinical and operational feedback to individual units and senior management is also provided

Make an enquiry

Benefits

Bioquell’s Norovirus Suppression Programme comprises a strategy based on best practice, which can be tailored to the specific requirements of the hospital. In effect, the plan is a pre-designed, pre-planned reactive service. It involves Bioquell engineers and equipment deploying rapidly to a hospital site at the onset of the outbreak, sometimes with equipment pre-located at the hospital. They then remain there to limit the spread of Norovirus by performing room or unit bio-decontaminations until the Norovirus outbreak has been arrested.

During the peak of a Norovirus outbreak, the Bioquell deployment will run in a very similar manner to Bioquell’s Proactive service, with personnel integrated within the hospital undertaking the Norovirus response on a daily basis. By reducing the extent of outbreaks and allowing more efficient cohorting, the Bioquell Norovirus suppression plan can help minimise unit closures, allowing hospitals to improve patient throughput and bed availability during the busy winter months. Hospitals can then achieve significant cost benefit by admitting additional patients to increase revenue generation. Further costs will also be saved by reducing the requirement for temporary replacement staff as Norovirus outbreaks are contained.

  “We feel that using Bioquell has helped reduce the spread of Norovirus in our hospital over the last two years, and now forms a critical part of our Norovirus remediation procedures.”
Ann Kerrane, Matron for infection prevention and control, The Rotherham NHS Foundation Trust.

Make an enquiry

FAQs

 
What is your evidence that using Bioquell will reduce Norovirus?

Norovirus transmission is known to have a large environmental component, as it survives in the environment for a long time and has an extremely low infective dose. There is anecdotal evidence from hospitals that using Bioquell has helped reduce the spread of Norovirus, though no research has yet been published. Bioquell is interested in collaborating with a hospital on such research.

Make an enquiry

Highlights

Bioquell RBDS provides a safe, reliable bio-decontamination solution to help heathcare professionals tackle hospital aquired infections (HAI/HCAI) and stop outbreaks of drug resistant pathogens. 

Read more about our room bio-decontamination services.

Highlights

Bioquell RBDS provides a safe, reliable bio-decontamination solution to help heathcare professionals tackle hospital aquired infections (HAI/HCAI) and stop outbreaks of drug resistant pathogens. 

Read more about our room bio-decontamination services.

Sitemap